Acute lymphoblastic/lymphocytic leukemia is one of the most common type of cancers that mainly affects children. There are two types of acute lymphocytic leukemia; B-cell type and T-cell type, that can be treated by radiation therapy, chemotherapy, targeted therapy, and others. The global acute lymphocytic leukemia market is expected to witness considerable growth during the forecast period. Increasing prevalence of acute lymphoblastic leukemia is encouraging the players in the market to develop innovative treatments to cure such diseases; thereby, contributing to the growth of the market. According to the National Cancer Institute in 2017, the number of new cases of acute lymphoblastic leukemia in the US was around 1.7 per 100,000 population. With the increasing cases of acute lymphoblastic leukemia, the market players are focusing more on clinical trials, which is expected to fuel the market growth in the near future.
Request a free sample of our report on Global Acute Lymphoblastic Leukemia Market: https://www.omrglobal.com/request-sample/acute-lymphoblastic-leukemia-market
The acute lymphoblastic leukemia market is segmented on the basis of cell type, treatment, and end-user. The market on the basis of cell type is bifurcated into B-cell type and T-Cell type. B-cell type segment is expected to contribute significantly to the growth of the market as 75% of acute lymphoblastic leukemia cases in adults develop from precursors of the B-cell lineage in the US, according to the National Institute of Health in 2017. As per treatment, the market is segmented into chemotherapy, radiation therapy, targeted therapy, immunotherapy, and stem cell transplantation. Among these, chemotherapy is expected to hold significant share in the global acute lymphoblastic leukemia market.
A full report of Global Acute Lymphoblastic Leukemia Market Is available at https://www.omrglobal.com/industry-reports/acute-lymphoblastic-leukemia-market
Global Acute Lymphoblastic Leukemia Market Segmentation
By Cell Type
Stem Cell Transplantation
Hospitals and Clinics
Rest of Europe
Rest of Asia-Pacific
Rest of the World
Adaptive Biotechnologies Corp.
Atara Biotherapeutics, Inc.
Baxter International, Inc.
Blubird Bio, Inc.
Bristol-Myers Squibb Co.
Cabaletta Bio, Inc.
For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/acute-lymphoblastic-leukemia-market
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting, and other research-based services.
For More Information, Visit https://www.omrglobal.com/
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 780-304-0404